Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

Market Cap	1.23T -1.7%
Revenue (ttm)	1.68T +0.3%
Net Income	59.24B -68.7%
EPS	4,500.58 -66.9%
Shares Out	13.18M
PE Ratio	20.75
Forward PE	18.53
Dividend	1,100.00 (1.18%)
Ex-Dividend Date	n/a

Volume	54,177
Average Volume	51,693
Open	95,000
Previous Close	93,400
Day's Range	92,900 - 95,200
52-Week Range	70,900 - 106,800
Beta	0.37
RSI	70.97
Earnings Date	Feb 2, 2026

About KRX:185750

Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. The company provides prescription drugs for anti-hypertension, anti-hyperlipidemia, anti-diabetics, and immunosuppressants; over-the-counter medicine comprising headache remedies, dewormers, digestive aids, and vitamins; probiotics and Omega-3 supplements; and health drinks, hair dyes, and insecticides. It also exports its products. The company was founded in 1941 and is headquartered in Seoul, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1941
• Employees: 2,253
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 185750

Financial Performance

In 2024, KRX:185750's revenue was 1.59 trillion, a decrease of -4.97% compared to the previous year's 1.67 trillion. Earnings were 109.07 billion, a decrease of -48.68%.